Wealth Enhancement Advisory Services’s Ginkgo Bioworks DNA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$141K	Sell	12,462 -9,883	-44%	-$80.5K	﹤0.01%	3855
2026 Q2	$203K	Buy	22,345 +10,438	+88%	+$87.3K	﹤0.01%	3572
2026 Q1	$82.2K	Buy	+11,907	New	+$99K	﹤0.01%	3355
2024 Q1	–	Sell	-286	Closed	-$19.3K	–	2503
2023 Q4	$19.3K	Sell	286 -37	-11%	-$2.27K	﹤0.01%	2257
2023 Q3	$23.4K	Buy	+323	New	+$25.8K	﹤0.01%	2191

Other funds holding DNA

J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return

Modera Wealth Management Westwood, New Jersey $9.5B AUM 16% 1-Year Est. Return

Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Wealth Enhancement Advisory Services's DNA Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Ginkgo Bioworks (DNA) stake by 44% in Q3 2026, selling an estimated $80.5K and leaving 12,462 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #3855.

Wealth Enhancement Advisory Services first reported a position in DNA in Q3 2023 and has held it in 5 quarters since. The position peaked at $203K in Q2 2026. 33 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

Wealth Enhancement Advisory Services held 12,462 shares of Ginkgo Bioworks worth $141K as of Q3 2026.
Wealth Enhancement Advisory Services sold 9,883 Ginkgo Bioworks shares in Q3 2026, an estimated $80.5K.
Ginkgo Bioworks made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3855 holding.
Wealth Enhancement Advisory Services first reported a position in Ginkgo Bioworks in Q3 2023 and has held it in 5 quarters since.
Wealth Enhancement Advisory Services's Ginkgo Bioworks position peaked at $203K in Q2 2026.
33 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.